Koyfin Home > Directory > Health Care > Acorda Therapeutics > Other Liabilities

Acorda Therapeutics Other Liabilities Chart (ACOR)

Acorda Therapeutics annual/quarterly Other Liabilities from 2010 to 2020.
  • Acorda Therapeutics Other Liabilities for the quarter ending June 06, 2020 was $122m a -8.05% decrease of -10m year over year
  • Acorda Therapeutics Other Liabilities for the last 12 months ending June 06, 2020 was $122m a -8.05% decrease of -10m year over year
  • Acorda Therapeutics Annual Other Liabilities for 2019 was $161m a -26.69% decrease of -43m from 2018
  • Acorda Therapeutics Annual Other Liabilities for 2018 was $204m a 2.32% increase of 5m from 2017
  • Acorda Therapeutics Annual Other Liabilities for 2017 was $200m a -3.33% decrease of -7m from 2016
Other Balance Sheet Metrics:
  • Acorda Therapeutics Total Assets for the quarter ending December 12, 2018 was $1,300m a 8.66% increase of 113m year over year
  • Acorda Therapeutics Total Equity for the quarter ending December 12, 2018 was $612m a 10.14% increase of 62m year over year
View Chart On Koyfin

Quarterly ACOR Other Liabilities Data

06/2020$122m
03/2020$135m
12/2019$161m
09/2019$131m
06/2019$184m
03/2019$198m
12/2018$204m
09/2018$236m
06/2018$185m
03/2018$183m

Annual ACOR Other Liabilities Data

2019$161m
2018$204m
2017$200m
2016$206m
2015$126m
2014$121m
2013$67m
2012$76m
2011$82m
2010$91m